Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-08 | 2023-09-22 | 142175 |
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144448 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144451 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144454 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144494 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144497 |
ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2021-12-22 | 151445 |
TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-01-20 | 2022-02-17 | 153186 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162280 |
TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-06-16 | 2022-10-29 | 162858 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167174 |
TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169951 |
TEVA-PRAZOSIN | 1MG | TABLET | Actual shortage | 2022-11-14 | 2023-12-21 | 174592 |
TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
ZADITEN | 1MG | TABLET | Resolved | 2022-12-08 | 2023-04-15 | 177535 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190722 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195127 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |